Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2020 / Jan / Mutation Detective
Digital and computational pathology Technology and innovation Biochemistry and molecular biology Genetics and epigenetics Research and Innovations

Mutation Detective

A new tool could predict whether cancer patients will benefit from immunotherapy

By Luke Turner 01/14/2020 Quick Read (pre 2022) 1 min read

Share

Nonsense mutations in the DNA disrupt protein synthesis and can lead to hereditary diseases and cancer. The human immune system generally recognizes and remove these nonsense mutations in a process called nonsense-mediated mRNA decay (NMD) – but new research shows that NMD can actually result in greater disease severity, especially in cancer patients, where NMD may prevent tumor cells from being exposed to the immune system (1).

Using a machine learning approach, one research team created a tool called NMDetective that describes every possible nonsense mutation – and then used it to analyze thousands of genetic variants leading to hereditary diseases. “We think that pharmacological NMD inhibition could potentially treat the symptoms of various genetic diseases,” explains Fran Supek, senior author of the research. By analyzing a tumor’s mutations, the NMDetective algorithm can provide insight into how a patient is likely to respond to immunotherapy, enabling more personalized treatment.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. R Lindeboom et al., “The impact of nonsense-mediated mRNA decay on genetic disease, gene editing and cancer immunotherapy”, Nat Genet, 51, 1645 (2019). PMID: 31659324.

About the Author(s)

Luke Turner

While completing my undergraduate degree in Biology, I soon discovered that my passion and strength was for writing about science rather than working in the lab. My master’s degree in Science Communication allowed me to develop my science writing skills and I was lucky enough to come to Texere Publishing straight from University. Here I am given the opportunity to write about cutting edge research and engage with leading scientists, while also being part of a fantastic team!

More Articles by Luke Turner

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Global Referral
Digital and computational pathology
Global Referral

January 12, 2024

10 min read

How digital pathology is transforming the delivery of remote second opinions

Cracking Colon Cancer
Digital and computational pathology
Cracking Colon Cancer

January 25, 2024

1 min read

How a new clinically approved AI-based tool enables rapid microsatellite instability detection

The (Pathology) IT Crowd?
Digital and computational pathology
The (Pathology) IT Crowd?

December 30, 2021

5 min read

The pathologist’s guide to IT considerations for digitization

Defining the Next Generation of NGS
Digital and computational pathology
Defining the Next Generation of NGS

December 31, 2021

1 min read

Overcoming challenges of the typical NGS workflow with the Ion Torrent™ Genexus™ System

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.